Bożena Kukiełka-Budny

Ribociclib plus Endocrine Therapy in Early Breast Cancer

Dennis J. Slamon, Oleg Lipatov, Zbigniew Nowecki et al. · New England Journal of Medicine · 2024 · 357 citations

Medicine, Oncology, Pharmacology +15

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Lori J. Goldstein, Mauro Mansutti, Christelle Lévy et al. · Breast Cancer Research and Treatment · 2021 · 101 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy

Marzena Kamińska, Tomasz Ciszewski, Bożena Kukiełka-Budny et al. · Annals of Agricultural and Environmental Medicine · 2015 · 41 citations · Full text

Medicine, Oncology, Breast Oncology +7

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis

Karen A. Gelmon, Peter A. Fasching, Fergus J. Couch et al. · European Journal of Cancer · 2021 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17